Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14873073Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$1.1M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#15,012
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Stephen Naylor as a PI. Multi-PI records show the full award amount for context.
- 1R44HL178153-01R44KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and pain$1Maward amount
- 3R44HL166018-02S1R44Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia$50Kaward amount
Award organization
Organizations that administered FY2025 awards listing Stephen Naylor as a PI.
FY2025 award administered by Reneurogen, Llc (WI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardReneurogen, Llc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6099
- 2025$2M Cumulative Funding